Exploring microRNAs as predictive biomarkers for type 2 diabetes mellitus remission after sleeve gastrectomy: A pilot study.

Autor: Wojciechowska G; Clinical Research Centre, Medical University of Białystok, Białystok, Poland., Szczerbinski L; Clinical Research Centre, Medical University of Białystok, Białystok, Poland.; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Białystok, Poland., Kretowski M; Faculty of Computer Science, Białystok University of Technology, Białystok, Poland., Niemira M; Clinical Research Centre, Medical University of Białystok, Białystok, Poland., Hady HR; 1st Clinical Department of General and Endocrine Surgery, Medical University of Białystok, Białystok, Poland., Kretowski A; Clinical Research Centre, Medical University of Białystok, Białystok, Poland.; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Białystok, Poland.
Jazyk: angličtina
Zdroj: Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2022 Feb; Vol. 30 (2), pp. 435-446.
DOI: 10.1002/oby.23342
Abstrakt: Objective: This study aimed to evaluate microRNAs (miRNAs) as predictive biomarkers for type 2 diabetes (T2D) remission 12 months after sleeve gastrectomy (SG).
Methods: A total of 179 serum miRNAs were profiled, and 26 clinical variables were collected from 46 patients. Two patients were later excluded because of hemolysis, and six patients with unclear remission status were set aside to evaluate the prediction models. The remaining 38 patients were included for model building. Variable selection was done using different approaches, including Least Absolute Shrinkage and Selection Operator (LASSO). Prediction models were then developed using LASSO and assessed in the validation set.
Results: A total of 26 out of 38 patients achieved T2D remission 12 months after SG. The prediction model with only clinical variables misclassified two patients, which were correctly classified using miRNAs. Two miRNA-only models achieved an accuracy of one but performed poorly for the validation set. The best miRNA model was a mixed model (accuracy: 0.974) containing four miRNAs (hsa-miR-32-5p, hsa-miR-382-5p, hsa-miR-1-3p, and hsa-miR-21-5p) and four clinical variables (T2D medication, sex, age, and fasting blood glucose). These miRNAs are involved in pathways related to obesity and insulin resistance.
Conclusions: This study suggests that four serum miRNAs might be predictive biomarkers for T2D remission 12 months after SG, but further validation studies are needed.
(© 2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society (TOS).)
Databáze: MEDLINE
Externí odkaz: